Methods to avoid infections in patients with inflammatory bowel disease.
Infections have been reported in patients with inflammatory bowel disease (IBD), especially in association with anti-inflammatory and immunomodulatory medications used to treat IBD. Unfortunately, there is a dearth of information on infectious complication risk in patients with IBD. This review describes infectious complications reported in patients with IBD and provides a framework for future studies to assess potential risk factors and incidence for infection. Recommendations are also provided for prevention of infection.
Aberra
Faten N
FN
Division of Gastroenterology, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA. Faten.aberra@uphs.upenn.edu
Lichtenstein
Gary R
GR
D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D015984:Causality; D003140:Communicable Disease Control; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007239:Infections / Q000209:etiology*; D015212:Inflammatory Bowel Diseases / Q000150:complications* / Q000188:drug therapy; D009894:Opportunistic Infections / Q000209:etiology / Q000517:prevention & control*
D000893:Anti-Inflammatory Agents; D007155:Immunologic Factors; D007166:Immunosuppressive Agents